Professor Ruth DobsonProfessor of Clinical NeurologyEmail: ruth.dobson@qmul.ac.ukProfileResearchPublicationsSupervisionProfileProfessor Ruth Dobson is Centre Lead for the Centre of Preventive Neurology at the Wolfson Institute of Population Health, QMUL. Her research has a focus on the roles of ethnicity, deprivation, gender and wider social determinants of health in MS, and she is particularly interested in ensuring that all people with MS are represented in research. She led the publication of UK guidelines on pregnancy in MS, and leads the UK MS pregnancy register. She is Chair of the ABN Advisory Group for MS and neuroinflammation, is a member of the NHS England Neurology clinical reference group, and the UK representative on ECTRIMS Council. She is currently Strategic Lead for Dementia at UCL Partners, chairs the MS Trust Advisory group and is chair of the Cure Parkinson’s Trust Research Committee. She additionally chairs the Research, Culture and Environment committee for the Faculty of Medicine and Dentistry. She was identified by the Royal College of Physicians as an Emerging Women Leader in 2020. In 2023 she was awarded the individual MS Brain Health award for her work in pregnancy and MS. Her research has been supported by the NMSS, MS Society, Horne Family Foundation, Barts Charity, BMA Foundation, MRC and NIHR. She has over 140 peer reviewed publications. ResearchResearch Interests:Multiple sclerosis Gender Pregnancy Gender-specific healthcare Ethnicity Deprivation Social Determinants of health Epidemiology Equity Risk-benefit analysis PublicationsKey Publications COVID-19 Vaccine Response in People with Multiple Sclerosis Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis Summary-data-based Mendelian randomization prioritizes potential druggable targets for multiple sclerosis Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines Vukusic S, Bove R, Dobson R et al. (2025). Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab. nameOfConference DOI: 10.1212/nxi.0000000000200349 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/102907 Chen B, Francis A, Cooper SA et al. (2025). Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum Disorder. nameOfConference DOI: 10.1212/wnl.0000000000210137 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/102906 Pace S, Messina S, Chen B et al. (2024). Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody‐associated disease: A national case series. nameOfConference DOI: 10.1111/ene.16550 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/101867 Rashid W, Ciccarelli O, Leary SM et al. (2024). Using disease-modifying treatments in multiple sclerosis: Association of British Neurologists (ABN) 2024 guidance.. nameOfConference DOI: 10.1136/pn-2024-004228 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/101598 Arun T, Petheram K, Tallantyre E et al. (2024). Assessing the landscape and charting paths: UK neurology trainees’ opinions on neuroinflammation subspecialty. nameOfConference DOI: 10.1016/j.msard.2024.106144 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/101703 Jacobs BM, Stow D, Hodgson S et al. (publicationYear). Genetic architecture of routinely acquired blood tests in a British South Asian cohort. nameOfConference DOI: 10.1038/s41467-024-53091-x QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/100687 Amezcua L, Rotstein D, Shirani A et al. (2024). Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia. nameOfConference DOI: 10.1016/s1474-4422(24)00288-6 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99895 Jacobs BM, Schalk L, Tregaskis-Daniels E et al. (2024). The relationship between ethnicity and multiple sclerosis characteristics in the United Kingdom: A UK MS Register study. nameOfConference DOI: 10.1177/13524585241277018 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99881 Francis A, Santos M, Leal Rato M et al. (2024). Study of seasonality of attacks in MOG antibody-associated disease. nameOfConference DOI: 10.1016/j.msard.2024.105814 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/99142 Zaloum SA, Mahesh M, Cetin MA et al. (2024). Diversity and representation within the literature on sexual dysfunction in multiple sclerosis: A systematic review. nameOfConference DOI: 10.1016/j.msard.2024.105767 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/98552 De Dios Perez B, Pritchard C, Powers K et al. (2024). The Impact of COVID-19 on the Employment of People With Multiple Sclerosis: A Multiple Methods Study.. nameOfConference DOI: 10.7224/1537-2073.2023-049 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/94416 Petheram K, Dobson R (2024). All women with multiple sclerosis should start hormone replacement therapy at menopause unless contraindicated: Commentary. nameOfConference DOI: 10.1177/13524585241254989 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/97859 Zhang Q, Noyce AJ, Robson J et al. (2024). No association between oral contraceptive exposure and subsequent MS: A population-based nested case–control study in primary care. nameOfConference DOI: 10.1177/13524585241258691 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/97520 Dobson R, Patterson K, Malik R et al. (2024). Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s disease. nameOfConference DOI: 10.1136/jnnp-2024-333468 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/97564 Devine H, Jabbari E, Scott J et al. (2024). Academic neurology in the UK: a plea to turn away from the precipice. nameOfConference DOI: 10.1093/brain/awae151 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/97061 Gklinos P, Dobson R (publicationYear). Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management. nameOfConference DOI: 10.3390/antib13020043 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/97063 Patyjewicz M, Mair D, Zaloum SA et al. (2024). Recreational nitrous oxide and thrombotic events: a case series. nameOfConference DOI: 10.1136/bmjno-2023-000619 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95129 Bove R, Pietrasanta C, Oreja-Guevara C et al. (2024). Pregnancy and Infant Outcomes in Females Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of over 3,000 Pregnancies to Date (S7.004). nameOfConference DOI: 10.1212/wnl.0000000000205585 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/96456 Tallantyre EC, Dobson R, Froud JLJ et al. (2024). Real‐world persistence of multiple sclerosis disease‐modifying therapies. nameOfConference DOI: 10.1111/ene.16289 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/96304 Vukusic S, Hellwig K, Oreja-Guevara C et al. (2024). Données de grossesses et des enfants de femmes recevant ocrelizumab pour le traitement de la sclérose en plaques : analyse de la plus grande base de données disponible. nameOfConference DOI: 10.1016/j.neurol.2024.02.268 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95910 Kuri A, Henshall DE, Chaudhry D et al. (publicationYear). Delays in Multiple Sclerosis diagnosis (DIMES): protocol for a multicentre, observational study of multiple sclerosis diagnostic pathways in the United Kingdom and Republic of Ireland. nameOfConference DOI: 10.1186/s12883-024-03598-z QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95908 Leal Rato M, Chen B, Francis A et al. (2024). A study of referral bias in NMOSD and MOGAD cohorts. nameOfConference DOI: 10.1016/j.msard.2024.105553 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95538 Nasir M, Hone L, Tallantyre E et al. (2024). Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. nameOfConference DOI: 10.1016/j.msard.2024.105528 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95327 Thomson A, Stennett A, Metin C et al. (2024). Under & Over: A randomised controlled study to develop an upper limb rehabilitation tool for people with Multiple Sclerosis. nameOfConference DOI: 10.1016/j.msard.2024.105529 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95172 Jacobs BM, Vickaryous N, Giovannoni G et al. (2024). Plasma proteomic profiles of UK Biobank participants with multiple sclerosis. nameOfConference DOI: 10.1002/acn3.51990 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/94365 Foote IF, Bandres‐Ciga S, Kim JJ et al. (2023). A Multivariate Genome‐Wide Association Study of the Shared Genetic Architecture Among Modifiable Risk Factors for Dementia: 590 Loci Associated with Brain Health. nameOfConference DOI: 10.1002/alz.079738 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93791 Dobson R (publicationYear). A phase 2 open-label clinical trial to determine the effect of Famciclovir on Epstein-Barr virus activity as measured by EBV shedding in the saliva of patients with Multiple Sclerosis. nameOfConference DOI: 10.1177/13524585231215268 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/93320 Hellwig K, Oreja-Guevara C, Vukusic S et al. (2023). Pregnancy and Infant Outcomes in Women Receiving Ocrelizumab for the Treatment of Multiple Sclerosis: Analysis of the Largest Available Outcomes Database. nameOfConference DOI: 10.1016/j.msard.2023.105306 QMRO: qmroHref Bernard Healey SA, Giovannoni G, Noyce A et al. (2024). Impact of multiple sclerosis risk alleles on the plasma proteome. nameOfConference DOI: 10.1093/brain/awad363 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/91694 Jacobs BM, Tank P, Bestwick JP et al. (2024). Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case–control study in an English population-based cohort. nameOfConference DOI: 10.1007/s00415-023-11971-0 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90685 Leddy S, Dobson R (2023). Multiple sclerosis. nameOfConference DOI: 10.1016/j.mpmed.2023.06.005 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90172 Liu C, Pace S, Bromley R et al. (2023). Exposure to medication for neurological disease in pregnancy – time to consider the long-term implications?. nameOfConference DOI: 10.1016/j.eclinm.2023.102157 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90416 Fan JH, Alexander J, Poole S et al. (2023). Characteristics of multiple sclerosis and demyelinating disease in an Asian American population. nameOfConference DOI: 10.1177/13524585231188486 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/90171 Dobson R, Ovadia C, Mathews J et al. (2023). Prescribing in pregnancy: navigating risks and benefits. nameOfConference DOI: 10.1136/pn-2023-003812 QMRO: qmroHref Chen B, Gomez‐Figueroa E, Redenbaugh V et al. (2023). Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?. nameOfConference DOI: 10.1002/ana.26731 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/89522 Dobson R (2023). Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination. nameOfConference DOI: 10.1177/13524585231185247 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/86261 Lee CD, Galetta SL, Dobson R (2023). Management of Possible Multiple Sclerosis. nameOfConference DOI: 10.1056/nejmclde2300812 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/84507 Dobson R, Jacobs B (2023). Early depressive symptoms and disability accrual in Multiple Sclerosis - a UK MS Register study. nameOfConference DOI: 10.1038/s41598-023-34545-6 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/86258 Gklinos P, Dobson R (publicationYear). Monoclonal Antibodies in Pregnancy and Breastfeeding in Patients with Multiple Sclerosis: A Review and an Updated Clinical Guide. nameOfConference DOI: 10.3390/ph16050770 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88869 Jacobs BM, Schalk L, Dunne A et al. (2023). ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK. nameOfConference DOI: 10.1136/bmjopen-2023-071656 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/88025 Fan J, Alexander J, Poole S et al. (2023). Characteristics of Multiple Sclerosis and Demyelinating Disease in an Asian American Population (P9-3.009). nameOfConference DOI: 10.1212/wnl.0000000000203972 QMRO: qmroHref Bove R, Amato MP, Dobson R et al. (2023). Pregnancy Outcomes in Patients With MS Following Exposure to Ofatumumab: Updated Results From the Novartis Safety Database (P9-3.014). nameOfConference DOI: 10.1212/wnl.0000000000202940 QMRO: qmroHref Oreja-Guevara C, Vukusic S, Pietrasanta C et al. (2023). Données de grossesses et des enfants de femmes recevant ocrélizumab pour le traitement de la sclérose en plaques. nameOfConference DOI: 10.1016/j.neurol.2023.01.672 QMRO: qmroHref Dobson R (2023). Family planning and multiple sclerosis. nameOfConference DOI: 10.1016/S1474-4422(22)00426-4 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/82424 Krysko KM, Dobson R, Alroughani R et al. (2023). Family planning considerations in people with multiple sclerosis. nameOfConference DOI: 10.1016/s1474-4422(22)00426-4 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/85551 Dobson R, Jacobs B, Marshall C (2023). Polygenic risk score prediction of Multiple Sclerosis in individuals of South Asian ancestry. nameOfConference DOI: 10.1093/braincomms/fcad041 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82423 Dobson R (2023). Menopause in women with multiple sclerosis: clinical symptoms, therapeutic considerations and possible impact on the course of the disease. nameOfConference DOI: 10.12968/bjnn.2023.19.Sup1.S34 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/83643 Dobson R (2023). Developing evidence-based guidelines for the safety of symptomatic drugs in multiple sclerosis (MS) during pregnancy and breastfeeding: a systematic review and Delphi consensus. nameOfConference DOI: 10.1177/13524585221148094 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/83644 Teelucksingh S, Govind RM, Dobson R et al. (publicationYear). Treating Vestibular Migraine When Pregnant and Postpartum: Progress, Challenges and Innovations. nameOfConference DOI: 10.2147/ijwh.s371491 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/84863 Dobson R, Rehill N, Weil RS (2023). Democratising access to dementia research. nameOfConference DOI: 10.47795/sqwe8437 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/95909 Noyce A (2022). The association between anti-epileptic drugs and incident Parkinson’s disease in UK Biobank. nameOfConference DOI: 10.1001/jamaneurol.2022.4699 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/82500 Dreyer-Alster S, Achiron A, Giovannoni G et al. (publicationYear). No evidence for an association between alcohol consumption and Multiple Sclerosis risk: a UK Biobank study. nameOfConference DOI: 10.1038/s41598-022-26409-2 QMRO: qmroHref Iyer P, Dobson R (2023). Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies. nameOfConference DOI: 10.1007/s40120-022-00421-0 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/83098 Hartmann M, Fenton N, Dobson R (2022). Development of Bayesian Network for Multiple Sclerosis Risk Factor Interaction Analysis. nameOfConference DOI: 10.1007/978-3-031-20837-9_2 QMRO: qmroHref Dobson R (2022). Social determinants of health and their impact in multiple sclerosis. nameOfConference DOI: 10.1038/s41582-022-00735-5 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/80535 Kuri A, Vickaryous N, Awad A et al. (2023). Vitamin D genetic risk scores in multiple sclerosis. nameOfConference DOI: 10.1007/s00415-022-11466-4 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/82470 Dobson R, Bove R (2022). In Vitro Fertilization and Multiple Sclerosis: Evolving Treatments and Reducing Relapse Risk.. nameOfConference DOI: 10.1212/WNL.0000000000201242 QMRO: qmroHref Jacobs BM, Peter M, Giovannoni G et al. (2022). Towards a global view of multiple sclerosis genetics. nameOfConference DOI: 10.1038/s41582-022-00704-y QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80522 Simpson-Yap S, Pirmani A, Kalincik T et al. (2022). Updated Results of the COVID-19 in MS Global Data Sharing Initiative. nameOfConference DOI: 10.1212/nxi.0000000000200021 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80533 Dobson R, Bove R (2022). In Vitro Fertilization and Multiple Sclerosis. nameOfConference DOI: 10.1212/wnl.0000000000201242 QMRO: qmroHref Simpson-Yap S, Pirmani A, De Brouwer E et al. (2022). Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β. nameOfConference DOI: 10.1016/j.msard.2022.104072 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80518 Dobson R, Tanasescu R, Gran B (publicationYear). Editorial: Preventing multiple sclerosis. nameOfConference DOI: 10.3389/fneur.2022.982411 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80121 Dobson R, Rog D, Ovadia C et al. (2023). Anti-CD20 therapies in pregnancy and breast feeding: a review and ABN guidelines. nameOfConference DOI: 10.1136/pn-2022-003426 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/79447 Dobson R (2022). Preventing Multiple Sclerosis - from evidence to action. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79448 K A-P, A S, T B et al. (2022). Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2022.104022 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79446 Rivas C, Anand K, Wu AF-W et al. (publicationYear). Lessons From the COVID-19 Pandemic to Improve the Health, Social Care, and Well-being of Minoritized Ethnic Groups With Chronic Conditions or Impairments: Protocol for a Mixed Methods Study. nameOfConference DOI: 10.2196/38361 QMRO: qmroHref Judge-Clayden F, Iyer P, Williams A et al. (2022). Multiple sclerosis, disease modifying therapies and pregnancy. nameOfConference DOI: 10.12968/bjnn.2022.18.sup3.s22 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/80524 Bove R, Hellwig K, Pasquarelli N et al. (2022). Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants. nameOfConference DOI: 10.1016/j.msard.2022.103963 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79188 Foote IF, Jacobs BM, Mathlin G et al. (2022). The shared genetic architecture of modifiable risk for Alzheimer's disease: a genomic structural equation modelling study. nameOfConference DOI: 10.1016/j.neurobiolaging.2022.02.016 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79699 Tallantyre EC, Scurr MJ, Vickaryous N et al. (2022). Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2022.103937 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/79178 Taylor T, Jacobs B, Giovannoni G et al. (2022). 211 The prevalence and characteristics of multiple sclerosis-associated uveitis in UK biobank. nameOfConference DOI: 10.1136/jnnp-2022-abn.240 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/92770 Jensen M, Jacobs B, Dobson R et al. (2022). Lower lymphocyte count is associated with increased risk of Parkinson’s disease. nameOfConference DOI: 10.1136/jnnp-2022-abn.306 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/78813 Belete D, Jacobs BM, Bestwick JP et al. (2022). Parkinson’s disease determinants, prediction and gene-environment interac- tions: a UK Biobank study. nameOfConference DOI: 10.1136/jnnp-2022-abn.21 QMRO: qmroHref Dobson R (2022). Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS). nameOfConference DOI: 10.1016/j.msard.2022.103894 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/78457 Baker D, MacDougall A, Kang AS et al. (2022). Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals?. nameOfConference DOI: 10.1093/cei/uxab015 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/78814 Hone L, Jacobs BM, Marshall C et al. (2022). Age-specific effects of childhood body mass index on multiple sclerosis risk. nameOfConference DOI: 10.1007/s00415-022-11161-4 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/86260 Simonet C, Bestwick J, Jitlal M et al. (2022). Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population. nameOfConference DOI: 10.1001/jamaneurol.2022.0003 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77358 Vukusic S, Dobson R, Bove RM et al. (2022). Données de grossesses chez des femmes recevant de l’ocrelizumab pour le traitement de la sclérose en plaques. nameOfConference DOI: 10.1016/j.neurol.2022.02.383 QMRO: qmroHref Dobson R (2022). Peripartum disease activity in moderately and severely disabled women with multiple sclerosis. nameOfConference DOI: 10.1177/2F20552173221104918 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/78456 Dobson R (2022). Challenges and Opportunities of Real-World Data: Statistical Analysis Plan for the Optimise:MS Multicenter Prospective Cohort Pharmacovigilance Study. nameOfConference DOI: 10.3389/fneur.2022.799531 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77920 Marshall CR, Noyce AJ, Neligan A et al. (2022). Brain health: The hidden casualty of a humanitarian crisis. nameOfConference DOI: 10.1016/j.lanepe.2022.100374 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/77761 Noyce A (2022). No evidence for association between polygenic risk of Multiple Sclerosis and MRI phenotypes in ~30,000 healthy adult UK Biobank participants. nameOfConference DOI: 10.1177/2F13524585221075744 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76333 Tur C, Dubessy A-L, Otero-Romero S et al. (2022). The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021. nameOfConference DOI: 10.1177/13524585211069068 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77359 Bothongo PLK, Jitlal M, Parry E et al. (2022). Dementia risk in a diverse population: A single-region nested case-control study in the East End of London. nameOfConference DOI: 10.1016/j.lanepe.2022.100321 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/75791 Hone L, Giovannoni G, Dobson R et al. (publicationYear). Predicting Multiple Sclerosis: Challenges and Opportunities. nameOfConference DOI: 10.3389/fneur.2021.761973 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76171 Dobson R, Chung K (2022). Natalizumab concentrations during pregnancy in three patients with multiple sclerosis: A clinical commentary. nameOfConference DOI: 10.1177/13524585211069922 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76679 Dobson R, Marshall C, Noyce A (2022). Social determinants of neurological disease: tackling inequalities. nameOfConference DOI: 10.1016/s1474-4422(22)00005-9 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76489 Satukijchai C, Mariano R, Messina S et al. (2022). Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom. nameOfConference DOI: 10.1001/jamanetworkopen.2021.42780 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76172 Geys L, Parciak T, Pirmani A et al. (2021). The Multiple Sclerosis Data Alliance Catalogue: Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources.. nameOfConference DOI: 10.7224/1537-2073.2021-006 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/77950 Baker D (2021). CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2021.103448 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75590 Dobson R, Craner M, Waddingham E et al. (2021). OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. nameOfConference DOI: 10.1136/bmjopen-2021-050176 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/76170 Geys L, Dobson R (2021). The Multiple Sclerosis Data Alliance Catalogue: enabling web-based discovery of metadata from real-world multiple sclerosis data sources. nameOfConference DOI: 10.7224/1537-2073.2021-006 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74105 Dobson R, Baker D, Kang A et al. (2021). COVID-19 vaccine response in people with multiple sclerosis. nameOfConference DOI: 10.1002/ana.26251 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74690 Huxford B, Haque T, Joseph AB et al. (2022). Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive Severity. nameOfConference DOI: 10.1002/mds.28829 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74651 Foote I, Jacobs B, Watson C et al. (2021). W26. A MULTIVARIATE GENOME-WIDE ASSOCIATION STUDY OF MODIFIABLE RISK FOR ALZHEIMER'S DISEASE: 269 LOCI ASSOCIATED WITH BRAIN HEALTH. nameOfConference DOI: 10.1016/j.euroneuro.2021.08.115 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75837 Camera V, Messina S, Elhadd KT et al. (2022). Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders. nameOfConference DOI: 10.1136/jnnp-2021-327206 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74547 Hone L, Jacobs BM, Marshall C et al. (publicationYear). Age-specific effects of childhood Body Mass Index on multiple sclerosis risk. nameOfConference DOI: 10.1101/2021.09.12.21263445 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/78265 Yam C, Rog D, Ford H et al. (2021). UK variance in DMT advice and prescribing in MS and pregnancy: impact of the UK consensus on pregnancy in multiple sclerosis ABN guidelines. nameOfConference DOI: 10.1016/j.msard.2021.103272 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/74545 Dobson R (2021). Differing Impact of DMT on Relapse and Progression: Time to Consider Inflammation and Neuroprotection Separately?. nameOfConference DOI: 10.1212/WNL.0000000000012356 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/72400 Kuri A, Jacobs BM, Leddy S et al. (2021). Evaluation of remote assessments for multiple sclerosis in an in-home setting. nameOfConference DOI: 10.1016/j.msard.2021.103125 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/73142 Leavitt VM, Dobson R, Svennigsson A (2021). Perinatal Depression and Anxiety in Multiple Sclerosis: Treatable Distress. nameOfConference DOI: 10.1212/WNL.0000000000012101 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71702 Garjani A, Hunter R, Law G et al. (2021). Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register. nameOfConference DOI: 10.1177/13524585211020435 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71706 Jacobs B, Dobson R (publicationYear). Ethnicity and multiple sclerosis – moving beyond preconceptions. nameOfConference DOI: 10.47795/dqjp9663 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/98914 Jacobs BM, Noyce AJ, Bestwick J et al. (2021). Gene-Environment Interactions in Multiple Sclerosis: A UK Biobank Study. nameOfConference DOI: 10.1212/nxi.0000000000001007 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70963 Dobson R, ALLEN-PHILBEY K, Giovannoni G et al. (2021). Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2021.103028 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71833 Garjani A, Middleton RM, Hunter R et al. (2021). COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies. nameOfConference DOI: 10.1016/j.msard.2021.102939 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71868 Taylor TRP, Galloway J, Davies R et al. (2021). Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis. nameOfConference DOI: 10.1212/NXI.0000000000000992 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/71027 Krysko KM, Bove R, Dobson R et al. (2021). Treatment of Women with Multiple Sclerosis Planning Pregnancy. nameOfConference DOI: 10.1007/s11940-021-00666-4 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74543 Jitlal M, Amirthalingam G, Karania T et al. (publicationYear). The influence of socioeconomic deprivation on dementia mortality, age at death and quality of diagnosis: a nationwide death records study in England and Wales 2001-2017. nameOfConference DOI: 10.3233/JAD-210089 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70919 Dobson R, Fenton N, Hartmann M (2021). Current Review and Next Steps for Artificial intelligence in Multiple Sclerosis risk research. nameOfConference DOI: 10.1016/j.compbiomed.2021.104337 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71187 Dobson R, Hellwig K (2021). Use of disease-modifying drugs during pregnancy and breastfeeding. nameOfConference DOI: 10.1097/wco.0000000000000922 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/71028 Foote IF, Jacobs BM, Mathlin G et al. (publicationYear). The Genetic Architecture of Alzheimer’s Disease Risk: A Genomic Structural Equation Modelling Study. nameOfConference DOI: 10.1101/2021.02.23.21252211 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/72648 Jensen MP, Jacobs BM, Dobson R et al. (2021). Lower Lymphocyte Count is Associated With Increased Risk of Parkinson's Disease. nameOfConference DOI: 10.1002/ana.26034 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70059 Hone L, Jacobs B, Noyce A et al. (2021). Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75629 Stennett A, Allen-Philbey K, Begum T et al. (2021). An evaluation of remote monitoring in people with MS during the COVID-19 pandemic. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75538 Bove R, Pasquarelli N, Borriello F et al. (2021). B-cell levels and immunity in breastfed infants of women with MS treated with ocrelizumab: design of a phase 4 study (SOPRANINO). nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75631 Huxford B, Haque T, Joseph A et al. (2021). HbA1c correlates with motor and cognitive outcome scores in patients with Parkinson's disease and type 2 diabetes. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74691 Dobson R, Bove R, Borriello F et al. (2021). Pregnancy and infant outcomes in women receiving ocrelizumab for the treatment of multiple sclerosis. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75637 Ostrem B, Anderson A, Conway S et al. (2021). Pregnancy outcomes and peripartum disease activity in moderately and severely disabled women with MS. nameOfConference DOI: doi QMRO: qmroHref Hellwig K, Pasquarelli N, Borriello F et al. (2021). Rationale and design of a phase 4 study exploring B-cell levels and immune responses in infants born to women with MS who were exposed to ocrelizumab up to 6 months before or during the first trimester of pregnancy (the MINORE study). nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75640 Vickaryous N, Asardag AN, Chance R et al. (2021). Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75630 Simpson-Yap S, Pirmani A, De Brouwer E et al. (2021). Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75636 Hartmann M, Fenton N, Dobson R (2021). Using Bayesian networks to understand multiple sclerosis risk factor interactions. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/75627 Vickaryous N, Jitlal M, Jacobs BM et al. (publicationYear). Remote testing of vitamin D levels across the UK MS population—A case control study. nameOfConference DOI: 10.1371/journal.pone.0241459 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69546 Jacobs BM, Smets I, Giovannoni G et al. (2021). Regarding: Nicotinic acetylcholine receptors α7 and α9 modify tobacco smoke risk for multiple sclerosis. nameOfConference DOI: 10.1177/1352458520969941 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69385 Bothongo PL, Jitlal M, Parry E et al. (2020). Ethnic and socioeconomic determinants of dementia risk: A nested case‐control study in the population of East London. nameOfConference DOI: 10.1002/alz.037869 QMRO: qmroHref Thomson A, Dobson R, Baker D et al. (2021). Digesting science: Developing educational activities about multiple sclerosis, prevention and treatment to increase the confidence of affected families. nameOfConference DOI: 10.1016/j.msard.2020.102624 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/70066 Auger SD, Jacobs BM, Dobson R et al. (2020). Big data, machine learning and artificial intelligence: a neurologist’s guide. nameOfConference DOI: 10.1136/practneurol-2020-002688 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67605 Auger S, Jacobs B, Dobson R et al. (2020). Navigating a world of big data, machine learning and artificial intelligence: a neurologist's guide. nameOfConference DOI: 10.1136/practneurol-2020-002688 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67242 Jacobs B, Belete D, Bestwick J et al. (2020). Parkinson’s disease determinants, prediction and gene-environment interactions in the UK Biobank. nameOfConference DOI: 10.1136/jnnp-2020-323646 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66809 Leddy S, Dobson R (2020). Multiple sclerosis. nameOfConference DOI: 10.1016/j.mpmed.2020.06.008 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/67140 Evangelou N, Garjani A, dasNair R et al. (2021). Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register. nameOfConference DOI: 10.1136/jnnp-2020-324449 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67162 Dobson R, Giovannoni G, Cuzick J (publicationYear). Estimated and projected burden of multiple sclerosis attributable to smoking and childhood and adolescent high body-mass index: a comparative risk assessment. nameOfConference DOI: 10.1093/ije/dyaa151 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66823 Dobson R (publicationYear). MS, pregnancy and COVID-19. nameOfConference DOI: 10.1177/1352458520949152 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66821 Jacobs B, Taylor T, Awad A et al. (2020). Summary-data-based mendelian randomisation prioritises potential druggable targets for Multiple Sclerosis. nameOfConference DOI: 10.1093/braincomms/fcaa119 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65644 Peeters LM, Parciak T, Walton C et al. (2020). COVID-19 in people with multiple sclerosis: A global data sharing initiative.. nameOfConference DOI: 10.1177/1352458520941485 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66201 Reyes S, Ramsay M, Ladhani S et al. (2020). Protecting people with multiple sclerosis through vaccination. nameOfConference DOI: 10.1136/practneurol-2020-002527 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68522 Krysko KM, Graves JS, Dobson R et al. (2020). Sex effects across the lifespan in women with multiple sclerosis. nameOfConference DOI: 10.1177/1756286420936166 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67928 Kuri A, Jacobs BM, Vickaryous N et al. (2020). Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. nameOfConference DOI: 10.1186/s12889-020-09049-x QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65285 Dobson R, Jokubaitis V, Giovannoni G (2020). Change in pregnancy-associated multiple sclerosis relapse rates over time: a meta-analysis. nameOfConference DOI: 10.1016/j.msard.2020.102241 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/64764 Taylor TR, Jacobs BM, Giovannoni G et al. (2020). Prevalence and demographics of multiple sclerosis-associated uveitis: a UK biobank study. nameOfConference DOI: 10.1016/j.msard.2020.102209 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66030 Dobson R, Mowry EM (2020). Breastfeeding may reduce postpartum relapse in some women with multiple sclerosis.. nameOfConference DOI: 10.1212/WNL.0000000000009369 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65298 Leddy S, Jacobs B, Giovannoni G et al. (2020). Bone health, fracture risk, and Multiple Sclerosis: a UK Biobank study (3946). nameOfConference DOI: 10.1212/wnl.94.15_supplement.3946 QMRO: qmroHref Jacobs B, Giovannoni G, Dobson R (2020). Environmental exposures associated with Multiple Sclerosis: a UK Biobank study (474). nameOfConference DOI: 10.1212/wnl.94.15_supplement.474 QMRO: qmroHref Dobson R, Yam C (2020). Pregnancy in multiple sclerosis: influence on disease trajectory. nameOfConference DOI: 10.47795/rmtu3215 QMRO: qmroHref Dobson R, Jacobs B, Giovannoni G et al. (publicationYear). Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors. nameOfConference DOI: 10.1177/1352458520907901 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/63739 Jokubaitis VG, Dobson R (2020). Reader response: Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis.. nameOfConference DOI: 10.1212/WNL.0000000000009063 QMRO: https://qmro.qmul.ac.uk/xmlui/handle/123456789/68388 Jokubaitis V, Dobson R (publicationYear). Family planning is the second most relevant factor for treatment decisions after disease activity. nameOfConference DOI: 10.1177/1352458520907902 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/63008 Dobson R, Jitlal M, Marshall CR et al. (2020). Ethnic and Socioeconomic Associations with Multiple Sclerosis Risk. nameOfConference DOI: 10.1002/ana.25688 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62858 Dobson R, Noyce A, Giovannoni G et al. (2020). BMI and low serum vitamin D are causal risk factors for Multiple Sclerosis: a Mendelian Randomisation study. nameOfConference DOI: 10.1212/NXI.0000000000000662 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/62737 Garjani A, Hunter R, Nicholas R et al. (2020). Anxiety affects the general well-being of people with ms during the COVID-19 pandemic more than the infection itself. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69804 Leddy S, Jacobs B, Giovannoni G et al. (2020). Bone health, fracture risk, and Multiple Sclerosis: a UK Biobank study. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68234 Garjani A, Evangelou N, Das Nair R et al. (2020). COVID-19 in people with MS: a large community-based study of the UK MS register. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69805 Taylor T, Luis J, Dobson R et al. (2020). Demographics of multiple sclerosis associated uveitis at moorfields eye hospital. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69807 Taylor T, Galloway J, Adam R et al. (2020). Demyelinating events following initiation of anti-tnfα therapy in the british society for rheumatology biologics registry in rheumatoid arthritis. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69808 Jacobs B, Giovannoni G, Dobson R (2020). Environmental exposures associated with Multiple Sclerosis: a UK Biobank study. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68240 Jacobs B, Noyce A, Bestwick J et al. (2020). Gene-environment interactions in multiple sclerosis: a uk biobank study. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69809 Belete D, Jacobs B, Bestwick J et al. (2020). Parkinson's disease determinants, prediction and gene-environment interactions in the UK Biobank. nameOfConference DOI: doi QMRO: qmroHref Leddy S, Jacobs BM, Giovannoni G et al. (2020). To examine the impact of Multiple Sclerosis on bone health and explore mechanisms for this association.. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67812 Vickaryous N, Garjani A, Jacobs B et al. (2020). Vitamin D levels in the UK MS population and COVID-19 susceptibility. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/69841 Jacobs BM, Giovannoni G, Cuzick J et al. (2019). Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors. nameOfConference DOI: 10.1177/1352458520907901 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/67272 DOBSON R (2019). Visibility and representation of women in multiple sclerosis research. nameOfConference DOI: 10.1212/WNL.0000000000007276 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/56468 Dobson R, Dassan P, Roberts M et al. (2019). UK consensus on pregnancy in multiple sclerosis: 'Association of British Neurologists' guidelines.. nameOfConference DOI: 10.1136/practneurol-2018-002060 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/54858 Dobson R, Jitlal M, Marshall C et al. (2019). Obesity is not associated with MS in a socially and ethnically diverse population. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66396 Vickaryous N, Jitlal M, Middleton R et al. (2019). Vitamin D levels in the UK MS population. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/66719 in IW (2018). Gender Inequities in the Multiple Sclerosis Community: A Call for Action. nameOfConference DOI: 10.1002/ana.25359 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/74544 Dobson R (2018). Clinical commentary on 'Life-threatening vitamin D intoxication due to intake of ultra-high doses in multiple sclerosis: a note of caution'.. nameOfConference DOI: 10.1177/1352458518807053 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/51423 Dobson R, Giovannoni G (2018). Multiple Sclerosis - a review.. nameOfConference DOI: 10.1111/ene.13819 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/48023 Thomson A, Aldam R, Giovannoni G (publicationYear). Making science digestible: the development of educational activities for children with a parent with MS, and the need to better engage families. nameOfConference DOI: 10.26226/morressier.5b719e485aff74008ae4cc60 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/65723 Dobson R, Cock HR, Brex P et al. (2018). Vitamin D supplementation. nameOfConference DOI: 10.1136/practneurol-2017-001720 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/51003 Dobson R, Kuhle J, Middeldorp J et al. (2017). Epstein-Barr-negative MS: a true phenomenon?. nameOfConference DOI: 10.1212/NXI.0000000000000318 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/34427 Middleton RM, Rodgers WJ, Giovannoni G et al. (2017). A Comparison of participant supplied EDSS scores and clinically submitted data via the UK MS Register. nameOfConference DOI: doi QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/64994 Dobson R, Ramagopalan S, Topping J et al. (2016). A Risk Score for Predicting Multiple Sclerosis.. nameOfConference DOI: 10.1371/journal.pone.0164992 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/18832 Binks S, Dobson R (2016). Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.. nameOfConference DOI: 10.1007/s11914-016-0320-5 QMRO: qmroHref DE Collins C, Ivry B, Bowen JD et al. (2016). A comparative analysis of Patient-Reported Expanded Disability Status Scale tools. nameOfConference DOI: 10.1177/1352458515616205 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/54862 Dobson R, Alvares D (2016). The difficulties with vitamin B12. nameOfConference DOI: 10.1136/practneurol-2015-001344 QMRO: qmroHref Topping J, Dobson R, Lapin S et al. (2016). The effects of intrathecal rituximab on biomarkers in multiple sclerosis. nameOfConference DOI: 10.1016/j.msard.2016.01.001 QMRO: qmroHref Disanto G, Adiutori R, Dobson R et al. (2016). Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. nameOfConference DOI: 10.1136/jnnp-2014-309690 QMRO: qmroHref Binks S, Dobson R (2015). Established, new and future disease modifying therapies for MS. nameOfConference DOI: 10.1002/pnp.399 QMRO: qmroHref Davis A, Dobson R, Kaninia S et al. (2016). Atraumatic needles for lumbar puncture: why haven't neurologists changed?. nameOfConference DOI: 10.1136/practneurol-2014-001055 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/10032 Disanto G, Adiutori R, Dobson R et al. (2016). Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome. nameOfConference DOI: 10.1136/jnnp-2014-309690 QMRO: qmroHref Kuhle J, Disanto G, Dobson R et al. (2015). Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. nameOfConference DOI: 10.1177/1352458514568827 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/7011 Leddy S, Fowler AJ, Giovanonni G et al. (2014). DEPRESSION IN MS: A SYSTEMATIC REVIEW AND META-ANALYSIS. nameOfConference DOI: 10.1136/jnnp-2014-309236.134 QMRO: qmroHref Cooper R, Doshi A, Harris P et al. (2014). IMMUNOCOMPETENT PML—AN IMMUNOLOGICAL SCOTOMA?. nameOfConference DOI: 10.1136/jnnp-2014-309236.112 QMRO: qmroHref Kuhle J, Gaiottino J, Leppert D et al. (2015). Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. nameOfConference DOI: 10.1136/jnnp-2013-307454 QMRO: qmroHref Disanto G, Dobson R, Pakpoor J et al. (publicationYear). The Refinement of Genetic Predictors of Multiple Sclerosis. nameOfConference DOI: 10.1371/journal.pone.0096578 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/54861 Shribman S, Torsney KM, Noyce AJ et al. (2014). A service development study of the assessment and management of fracture risk in Parkinson’s disease. nameOfConference DOI: 10.1007/s00415-014-7333-8 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/42544 Dobson R, Topping J, Chard D et al. (2014). A Multivariate Risk Calculator for Multiple Sclerosis and Study of an Endophenotype in Siblings of People with Multiple Sclerosis (S34.002). nameOfConference DOI: 10.1212/wnl.82.10_supplement.s34.002 QMRO: qmroHref Torsney KM, Noyce AJ, Doherty KM et al. (2014). Bone health in Parkinson's disease: a systematic review and meta-analysis. nameOfConference DOI: 10.1136/jnnp-2013-307307 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/37224 Shribman SE, Torsney K, Noyce AJ et al. (2014). A service development study of the assessment and management of fracture risk in Parkinson's disease. nameOfConference DOI: doi QMRO: qmroHref Torsney KM, Noyce AJ, Doherty KM et al. (2014). A systematic review and meta-analysis of fracture risk in Parkinson's disease. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Rudick RA, Turner B et al. (2014). Assessing treatment response to interferon-β Is there a role for MRI?. nameOfConference DOI: 10.1212/WNL.0000000000000036 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/43428 Torsney KM, Noyce AJ, Doherty KM et al. (2014). Bone health in Parkinson's disease: A systematic review and meta-analysis. nameOfConference DOI: doi QMRO: qmroHref Disanto G, Dobson R, Pakpoor J et al. (2014). Genetic predictors of multiple sclerosis. nameOfConference DOI: doi QMRO: qmroHref Raffel J, Dobson R, Gafson A et al. (2014). Multiple sclerosis therapy and Epstein–Barr virus antibody titres. nameOfConference DOI: 10.1016/j.msard.2013.12.004 QMRO: qmroHref Dobson R, Rudick RA, Turner B et al. (2014). Assessing treatment response to interferon-&bgr;. nameOfConference DOI: 10.1212/wnl.0000000000000036 QMRO: qmroHref Davis A, Dobson R, Kaninia S et al. (2014). Change practice now! Using atraumatic needles to prevent post lumbar puncture headache. nameOfConference DOI: 10.1111/ene.12307 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/12000 Leddy S, Hadavi S, Mc Carren A et al. (2013). A NOVEL INTERNET–BASED METHOD OF CAPTURING OUTCOMES IN MULTIPLE SCLEROSIS. nameOfConference DOI: 10.1136/jnnp-2013-306573.9 QMRO: qmroHref Hadavi S, Giovannoni G, Dobson R (2013). A SERVICE DEVELOPMENT AUDIT OF FAMPRIDINE USE IN MS. nameOfConference DOI: 10.1136/jnnp-2013-306573.178 QMRO: qmroHref Hadavi S, Shribman S, Nagy A et al. (2013). THE BRADYKINESIA–AKINESIA INCOORDINATION TEST: A SIMPLE OBJECTIVE TEST IN MULTIPLE SCLEROSIS. nameOfConference DOI: 10.1136/jnnp-2013-306573.184 QMRO: qmroHref Dobson R, McMillan A, Kung K et al. (2013). THINK OUTSIDE THE BOX, COLLAPSE THE BOX, AND TAKE A SHARP KNIFE TO IT!. nameOfConference DOI: 10.1136/jnnp-2013-306573.173 QMRO: qmroHref Dobson R, Topping J, Ramagopalan S et al. (2013). TOWARDS AN ENDOPHENOTYPE IN MULTIPLE SCLEROSIS. nameOfConference DOI: 10.1136/jnnp-2013-306573.31 QMRO: qmroHref James E, Dobson R, Kuhle J et al. (2013). The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis.. nameOfConference DOI: 10.1177/1352458513489756 QMRO: qmroHref Leddy S, Hadavi S, McCarren A et al. (2013). Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.. nameOfConference DOI: 10.1007/s00415-013-7004-1 QMRO: qmroHref Puentes F, Topping J, Kuhle J et al. (2014). Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis. nameOfConference DOI: 10.1136/jnnp-2013-305494 QMRO: qmroHref Gaiottino J, Norgren N, Dobson R et al. (publicationYear). Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases. nameOfConference DOI: 10.1371/journal.pone.0075091 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/54859 Dobson R, Giovannoni G (2013). Bone health in multiple sclerosis: should we be doing more?. nameOfConference DOI: 10.2217/nmt.13.46 QMRO: qmroHref Evdoshenko E, Maslyanskiy A, Lapin S et al. (2013). Dynamics of B‐Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone. nameOfConference DOI: 10.1155/2013/748127 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68755 Dobson R, Ramagopalan S, Davis A et al. (2013). Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.. nameOfConference DOI: 10.1136/jnnp-2012-304695 QMRO: qmroHref Hadavi S, Baker MD, Dobson R (2014). Sustained-release fampridine in Multiple Sclerosis. nameOfConference DOI: 10.1016/j.msard.2013.06.003 QMRO: qmroHref Dobson R, Giovannoni G (2013). Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis.. nameOfConference DOI: 10.1007/s00415-012-6790-1 QMRO: qmroHref Dobson R, Yarnall A, Noyce AJ et al. (2013). Bone health in chronic neurological diseases: a focus on Multiple sclerosis and Parkinsonian syndromes.. nameOfConference DOI: 10.1136/practneurol-2012-000435 QMRO: qmroHref Pakpoor J, Handel AE, Giovannoni G et al. (publicationYear). Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine. nameOfConference DOI: 10.1371/annotation/274e5ef1-79aa-48f7-af62-0594d5c1354e QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/5223 Dobson R, Giovannoni G, Ramagopalan S (2013). The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.. nameOfConference DOI: 10.1136/jnnp-2012-303934 QMRO: qmroHref Dobson R, Leddy SG, Gangadharan S et al. (2013). Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.. nameOfConference DOI: 10.1136/bmjopen-2012-002508 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/54863 Dobson R, Topping J, Davis A et al. (2013). Cerebrospinal fluid and urinary biomarkers in multiple sclerosis. nameOfConference DOI: 10.1111/ane.12119 QMRO: qmroHref Dobson R, Ramagopalan SV, Giovannoni G (2013). Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?. nameOfConference DOI: 10.1586/ern.13.13 QMRO: qmroHref Pakpoor J, Disanto G, Gerber JE et al. (2013). The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.. nameOfConference DOI: 10.1177/1352458512449682 QMRO: qmroHref Leddy S, Hadavi S, McCarren A et al. (2013). A novel internet-based method of capturing outcomes in multiple sclerosis. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Ramagopalan S, Davis A et al. (2013). Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude. nameOfConference DOI: 10.1136/jnnp-2012-304695 QMRO: qmroHref Dobson R, Topping J, Giovannoni G (2013). Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.. nameOfConference DOI: 10.1002/jmv.23446 QMRO: qmroHref Kuhle J, Dobson R, Bestwick JP et al. (2013). Multivariate clinically isolated syndrome (CIS) risk factor study: towards individual prognosis and treatment indication in CIS. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Giovannoni G, Ramagopalan S (2013). The month of birth effect in multiple sclerosis: Systematic review, meta-analysis and effect of latitude. nameOfConference DOI: 10.1136/jnnp-2012-303934 QMRO: qmroHref Dobson R, Ramagopalan S, Giovannoni G (2012). Bone health and multiple sclerosis.. nameOfConference DOI: 10.1177/1352458512453362 QMRO: qmroHref Dobson R, Ramagopalan S, Giovannoni G et al. (2012). Risk of fractures in patients with multiple sclerosis. nameOfConference DOI: 10.1212/01.wnl.0000422676.74031.07 QMRO: qmroHref Pakpoor J, Handel AE, Giovannoni G et al. (2012). Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine. nameOfConference DOI: 10.1371/journal.pone.0045295 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/54864 Dobson R, Ramagopalan S, Giovannoni G (2012). The effect of gender in clinically isolated syndrome (CIS): a meta-analysis.. nameOfConference DOI: 10.1177/1352458511426740 QMRO: qmroHref Dobson R (2012). Urine: An under-studied source of biomarkers in multiple sclerosis?. nameOfConference DOI: 10.1016/j.msard.2012.01.002 QMRO: qmroHref Dobson R, Rudick RA, Giovannoni G (2012). CAN WE RELIABLY USE MRI TO MONITOR TREATMENT RESPONSE IN PATIENTS ON INTERFERON β: A SYSTEMATIC REVIEW AND META-ANALYSIS. nameOfConference DOI: 10.1136/jnnp-2012-304200a.127 QMRO: qmroHref Davis A, Dobson R, Espasandin M et al. (2012). Cerebrospinal fluid biomarkers as outcome measures in clinical trials of MS: The significance of post lumbar puncture headaches. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Meier UC, Schmierer K et al. (2012). DO SIBLINGS OF PEOPLE WITH MULTIPLE SCLEROSIS (MS) HAVE MARKERS OF MS RISK?. nameOfConference DOI: 10.1136/jnnp-2011-301993.173 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/7015 Disanto G, Sandve GK, Berlanga-Taylor AJ et al. (2012). Genomic Regions Associated with Multiple Sclerosis Are Active in B Cells. nameOfConference DOI: 10.1371/journal.pone.0032281 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/4924 Dobson R, Ramagopalan S, Giovannoni G (2012). Osteoporosis and fracture risk in multiple sclerosis. nameOfConference DOI: doi QMRO: qmroHref Raffel J, Dobson R, Giovannoni G (2012). THE EFFECT OF NATALIZUMAB AND INTERFERON-β ON URINARY FREE LIGHT CHAINS AND ANTI-EBV NUCLEAR ANTIGEN-1 ANTIBODIES IN RELAPSING REMITTING MULTIPLE SCLEROSIS. nameOfConference DOI: 10.1136/jnnp-2011-301993.190 QMRO: qmroHref Topping J, Evdoshenko E, Dobson R et al. (2012). The effects of intrathecal rituximab on biomarkers in MS. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Topping J, Davis A et al. (2012). Urinary and CSF biomarkers in multiple sclerosis. nameOfConference DOI: doi QMRO: qmroHref Dobson R, Giovannoni G (2012). WHY CAN'T I WIN ANY MORE?. nameOfConference DOI: 10.1136/jnnp-2011-301993.200 QMRO: qmroHref Dobson R, Lawden M (2011). Melanoma associated retinopathy and how to understand the electroretinogram.. nameOfConference DOI: 10.1136/practneurol-2011-000061 QMRO: qmroHref Maghzi A-H, Marta M, Bosca I et al. (2011). Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?. nameOfConference DOI: 10.1016/j.pathophys.2010.04.003 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/68754 Handel AE, Williamson AJ, Disanto G et al. (2011). Smoking and Multiple Sclerosis: An Updated Meta-Analysis. nameOfConference DOI: 10.1371/journal.pone.0016149 QMRO: https://uat2-qmro.qmul.ac.uk/xmlui/handle/123456789/5463 Dobson R, Meier UC, Schmierer K et al. (2011). Do siblings have markers of multiple sclerosis risk?. nameOfConference DOI: doi QMRO: qmroHref Meier UC, Giovannoni G (2011). More to come: humoral immune responses in MS. nameOfConference DOI: 10.1016/j.jneuroim.2011.09.009 QMRO: qmroHref Dobson R, Meier UC, Marta M et al. (2011). Vitamin D deficiency - do we follow our own advice?. nameOfConference DOI: 10.7861/clinmedicine.11-6-521 QMRO: qmroHref Dobson R, Feldmann M, Thompson AJ et al. (2010). INCREASED URINARY FREE IMMUNOGLOBULIN LIGHT CHAIN EXCRETION IN PATIENTS WITH MULTIPLE SCLEROSIS. nameOfConference DOI: 10.1136/jnnp.2010.226340.159 QMRO: qmroHref Dobson R, Lawden M (2010). CP1 Darkness visible. nameOfConference DOI: 10.1136/jnnp.2010.226340.66 QMRO: qmroHref Ramagopalan SV, Dobson R, Meier UC et al. (2010). Multiple sclerosis: risk factors, prodromes, and potential causal pathways.. nameOfConference DOI: 10.1016/S1474-4422(10)70094-6 QMRO: qmroHref Dobson R, Miller RF, Palmer HE et al. (2010). Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis.. nameOfConference DOI: 10.1016/j.jneuroim.2010.01.012 QMRO: qmroHref SupervisionThe relationship between infections and MS (NIHR funded; Emily Tregaskis-Daniels, primary supervisor) Pathways to MS diagnosis (ESRC/LISS-DTP funded; Hiba Adan, primary supervisor) Using simulated large-scale datasets to enable research (Caroline Morton, secondary supervisor) EBV in ECVs in MS (Francesca Rios, primary supervisor) Menopause and MS (Imogen Collier, primary supervisor) Social capital in multiple sclerosis (Heather Mah, secondary supervisor)